Lloyd Peter Haskell, Age 704 Ups N Downs Ct, Flemington, NJ 08822

Lloyd Haskell Phones & Addresses

4 Ups N Downs Ct, Flemington, NJ 08822 (908) 782-0493

Henderson, NV

Windermere, FL

Huntington, CT

Bridgewater, NJ

Hopkinton, MA

Skillman, NJ

Worcester, MA

4 Ups N Downs Ct, Flemington, NJ 08822 (908) 625-2943

Show more

Social networks

Lloyd Peter Haskell

Linkedin

Work

Position: Professional/Technical

Education

School / High School: New York Medical College 1977

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Critical Care Medicine, 1989

Emails

Mentions for Lloyd Peter Haskell

Career records & work history

Medicine Doctors

Lloyd Haskell Photo 1

Dr. Lloyd P Haskell, Flemington NJ - MD (Doctor of Medicine)

Specialties:
Critical Care Medicine
Nephrology
Address:
4 Ups N Downs Ct, Flemington, NJ 08822
(908) 782-0493 (Phone)
Certifications:
Critical Care Medicine, 1989
Internal Medicine, 1980
Nephrology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York Medical College
Graduated: 1977
Medical School
Beth Israel Medical Center-Petrie Campus
Graduated: 1977
Medical School
New York University
Graduated: 1977
Lloyd Haskell Photo 2

Lloyd Peter Haskell

Specialties:
Internal Medicine
Nephrology

Lloyd Haskell resumes & CV records

Resumes

Lloyd Haskell Photo 27

Lloyd Haskell

Publications & IP owners

Us Patents

Combination Therapy Comprising Angiotensin Receptor Blockers And Vasopressin Receptor Antagonists

US Patent:
2010009, Apr 15, 2010
Filed:
Oct 8, 2009
Appl. No.:
12/575869
Inventors:
Bruce Damiano - Lansdale PA, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
International Classification:
A61K 31/55
A61P 13/00
US Classification:
51421202
Abstract:
The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin receptor blocker (ARB) and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin-mediated disorders.

Oxazolidinones For The Treatment And/Or Prophylaxis Of Heart Failure

US Patent:
2011000, Jan 6, 2011
Filed:
Dec 3, 2008
Appl. No.:
12/746661
Inventors:
Harald Kallabis - Koln, DE
Wolfgang Thielemann - Wuppertal, DE
Elisabeth Perzborn - Wuppertal, DE
Susanne Röhrig - Hilden, DE
Dagmar Kubitza - Ratingen, DE
Theodore Spiro - Pennington NJ, US
Lloyd Haskell - Flemington NJ, US
Jeet Mahal - San Francisco CA, US
International Classification:
A61K 31/5377
A61P 9/00
A61P 7/02
US Classification:
5142308
Abstract:
The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure.

Combination Therapy Comprising Angiotensin Converting Enzyme Inhibitors And Vasopressin Receptor Antagonists

US Patent:
2009011, May 7, 2009
Filed:
Nov 5, 2008
Appl. No.:
12/265098
Inventors:
Bruce Damiano - Warrington PA, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
International Classification:
A61K 31/55
A61P 9/04
A61P 9/12
A61P 9/10
A61P 25/00
US Classification:
51421202
Abstract:
The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin converting enzyme (ACE) inhibitor and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin converting enzyme mediated disorders.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.